Synaptic elimination and the complement system in Alzheimer’s disease
46
Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E,
Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B,
Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B,
Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE
mediates amyloid-beta peptide transport across the blood-brain
barrier and accumulation in brain. Nat Med 9 (7):907-913.
DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in
Alzheimer's disease: correlation with cognitive severity. Annals of
neurology 27 (5):457-464.
Dragunow M (2008) High-content analysis in neuroscience. Nature reviews
Neuroscience 9 (10):779-788.
Eroglu C, Allen NJ, Susman MW, O'Rourke NA, Park CY, Ozkan E,
Chakraborty C, Mulinyawe SB, Annis DS, Huberman AD, Green
EM, Lawler J, Dolmetsch R, Garcia KC, Smith SJ, Luo ZD,
Rosenthal A, Mosher DF, Barres BA (2009) Gabapentin receptor
alpha2delta-1 is a neuronal thrombospondin receptor responsible for
excitatory CNS synaptogenesis. Cell 139 (2):380-392.
Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC,
Momeni P (2012) Implication of common and disease specific
variants in CLU, CR1, and PICALM. Neurobiology of aging 33
(8):1846 e1847-1846 e1818.
Finehout EJ, Franck Z, Lee KH (2005) Complement protein isoforms in CSF
as possible biomarkers for neurodegenerative disease. Disease
markers 21 (2):93-101.
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A
practical method for grading the cognitive state of patients for the
clinician. Journal of psychiatric research 12 (3):189-198.
Fonseca MI, Zhou J, Botto M, Tenner AJ (2004) Absence of C1q leads to
less neuropathology in transgenic mouse models of Alzheimer's
disease. The Journal of neuroscience : the official journal of the
Society for Neuroscience 24 (29):6457-6465.
Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB, Lai KO, Yung WH,
Fu AK, Greenberg ME, Ip NY (2007) Cdk5 regulates EphA4-
mediated dendritic spine retraction through an ephexin1-dependent
mechanism. Nature neuroscience 10 (1):67-76.
Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill
LR, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations
in Alzheimer's disease and related dementias. Archives of neurology
51 (9):888-895.
Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S,
Fiske A, Pedersen NL (2006) Role of genes and environments for
explaining Alzheimer disease. Archives of general psychiatry 63
(2):168-174.
47
Gerrow K, El-Husseini A (2007) Receptors look outward: revealing signals
that bring excitation to synapses. Science's STKE : signal
transduction knowledge environment 2007 (408):pe56.
Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the
purification and characterization of a novel cerebrovascular amyloid
protein. Biochemical and biophysical research communications 120
(3):885-890.
Griffiths HH, Whitehouse IJ, Baybutt H, Brown D, Kellett KA, Jackson CD,
Turner AJ, Piccardo P, Manson JC, Hooper NM (2011) Prion protein
interacts with BACE1 protein and differentially regulates its activity
toward wild type and Swedish mutant amyloid precursor protein. J
Biol Chem 286 (38):33489-33500.
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI
(1986) Abnormal phosphorylation of the microtubule-associated
protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of
the National Academy of Sciences of the United States of America
83 (13):4913-4917.
Hanse E, Gustafsson B (2001) Paired-pulse plasticity at the single release site
level: an experimental and computational study. The Journal of
neuroscience : the official journal of the Society for Neuroscience 21
(21):8362-8369.
Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA
receptor signalling: implications for neurodegenerative disorders.
Nature reviews Neuroscience 11 (10):682-696.
Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic
dissection of Alzheimer's disease and related dementias: amyloid and
its relationship to tau. Nature neuroscience 1 (5):355-358.
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease:
progress and problems on the road to therapeutics. Science 297
(5580):353-356.
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML,
Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas
C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton
MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A,
Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd
S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead
S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B,
van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M,
Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS,
Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K,
Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G,
Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-
Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R,
Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N,
Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG,